Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Meliora Therapeutics Appoints Claudio Chuaqui as Head of Drug Discovery
Meliora Therapeutics, a biotech company pioneering a machine learning-driven approach to mechanism-driven oncology drug development, […]
Vertex and CRISPR Therapeutics Announce Licensing Agreement
Vertex Pharmaceuticals and CRISPR Therapeutics today announced that they have entered into a new non-exclusive […]
NRx Pharmaceuticals to Continue Enrollment in the Ongoing Trial of NRX-101 in Patients with Suicidal Treatment-Resistant Bipolar Depression
NRx Pharmaceuticals, a clinical-stage CNS biopharmaceutical company, today reported that the independent Data Safety Monitoring […]
Validic Integrates with Smart Meter
Validic, a market-leading digital health and personalized care company, continues to expand its healthcare IoT […]
SolasCure Announces Final Closing of £10.9m Series B Fundraise to Advance Wound Care Innovation
SolasCure, a biotechnology company developing a hydrogel containing a recombinant enzyme derived from maggots which […]
FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval
The United States Food and Drug Administration (FDA) issued draft guidance, Clinical Trial Considerations to […]
Incyte Announces Japanese Approval of Pemazyre® (pemigatinib) for the Treatment of Patients with Myeloid/Lymphoid Neoplasms (MLNs)
Incyte today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved […]
NHS Patients with Rare Genetic Disorders to be Fast-tracked to Earlier Diagnosis and Specialist Care
Hundreds of people with a range of rare conditions primarily affecting the central nervous system […]
Novartis Trial Shows Benefit in Patients with Breast Cancer
Novartis today announced positive topline results from an interim analysis of NATALEE, a Phase III […]
GeminiBio Strengthens Board of Directors with Addition of Bryan Poltilove
Gemini BioProducts (GeminiBio), a portfolio company of BelHealth, a Florida-based healthcare private equity firm, and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more